BridgeBio Pharma, Inc.
BBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $681,101 | $375,935 | $376,689 | $393,772 |
| Short-Term Investments | $0 | $58,949 | $95,233 | $442,891 |
| Receivables | $4,722 | $1,751 | $17,079 | $19,749 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $34,869 | $40,958 | $59,852 | $32,446 |
| Total Curr. Assets | $720,692 | $477,593 | $548,853 | $888,858 |
| Property Plant & Equip (Net) | $12,778 | $19,843 | $25,247 | $45,973 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $23,926 | $26,319 | $28,712 | $44,934 |
| Long-Term Investments | $143,747 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $18,195 | $22,625 | $20,224 | $33,027 |
| Total NC Assets | $198,646 | $68,787 | $74,183 | $123,934 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $919,338 | $546,380 | $623,036 | $1,012,792 |
| Liabilities | – | – | – | – |
| Payables | $9,618 | $10,655 | $11,558 | $11,884 |
| Short-Term Debt | $4,506 | $4,128 | $3,675 | $4,938 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $6,096 | $8,156 | $0 |
| Other Curr. Liab. | $140,276 | $122,965 | $98,039 | $118,247 |
| Total Curr. Liab. | $154,400 | $143,844 | $121,428 | $135,069 |
| LT Debt | $1,726,078 | $1,735,710 | $1,719,889 | $1,721,233 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $496,472 | $9,361 | $26,643 | $22,069 |
| Total NC Liab. | $2,222,550 | $1,745,071 | $1,746,532 | $1,743,302 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $9,202 | $13,109 | $15,949 | $22,366 |
| Total Liabilities | $2,376,950 | $1,888,915 | $1,867,960 | $1,878,371 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $196 | $181 | $157 | $154 |
| Retained Earnings | -$3,096,263 | -$2,560,501 | -$1,918,149 | -$1,436,966 |
| AOCI | $8 | $31 | -$328 | -$132 |
| Other Equity | $1,628,155 | $1,206,032 | $663,703 | $566,530 |
| Total Equity | -$1,467,904 | -$1,354,257 | -$1,254,617 | -$870,414 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $10,292 | $11,722 | $9,693 | $4,835 |
| Total Liab. & Tot. Equity | $919,338 | $546,380 | $623,036 | $1,012,792 |
| Net Debt | $1,049,483 | $1,363,903 | $1,346,875 | $1,332,399 |